27 reports of this reaction
1.4% of all ACETAMINOPHEN, DEXTROMETHORPHAN HBR reports
#18 most reported adverse reaction
OROPHARYNGEAL PAIN is the #18 most commonly reported adverse reaction for ACETAMINOPHEN, DEXTROMETHORPHAN HBR, manufactured by The Procter & Gamble Manufacturing Company. There are 27 FDA adverse event reports linking ACETAMINOPHEN, DEXTROMETHORPHAN HBR to OROPHARYNGEAL PAIN. This represents approximately 1.4% of all 1,934 adverse event reports for this drug.
Patients taking ACETAMINOPHEN, DEXTROMETHORPHAN HBR who experience oropharyngeal pain should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
OROPHARYNGEAL PAIN is a less commonly reported adverse event for ACETAMINOPHEN, DEXTROMETHORPHAN HBR, but still significant enough to appear in the safety profile.
In addition to oropharyngeal pain, the following adverse reactions have been reported for ACETAMINOPHEN, DEXTROMETHORPHAN HBR:
The following drugs have also been linked to oropharyngeal pain in FDA adverse event reports:
OROPHARYNGEAL PAIN has been reported as an adverse event in 27 FDA reports for ACETAMINOPHEN, DEXTROMETHORPHAN HBR. This does not prove causation, but indicates an association observed in post-market surveillance data.
OROPHARYNGEAL PAIN accounts for approximately 1.4% of all adverse event reports for ACETAMINOPHEN, DEXTROMETHORPHAN HBR, making it a notable side effect.
If you experience oropharyngeal pain while taking ACETAMINOPHEN, DEXTROMETHORPHAN HBR, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.